Showing results (241-250 of 264) with videos related to
Sort By:
Pageof 27
Bioorganic & Medicinal Chemistry Letters|June 14, 2005
(1H-imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: a novel class of potent MSK-1-inhibitorsMark J Bamford, Michael J Alberti, Nicholas Bailey, et al.Journal of Long-Term Effects of Medical Implants|November 1, 2006
Avian Flu pandemic in the United States. The Sanitec Industry's solutionRichard F Edlich, Lise Borel, H Gordon Jensen, et al.Journal of Long-Term Effects of Medical Implants|March 29, 2006
Revolutionary advances in medical waste management. The Sanitec systemRichard F Edlich, Lise Borel, H Gordon Jensen, et al.Bioorganic & Medicinal Chemistry Letters|October 12, 2010
Identification of 2-oxo-N-(phenylmethyl)-4-imidazolidinecarboxamide antagonists of the P2X(7) receptorLee Abberley, Aude Bebius, Paul J Beswick, et al.Bioorganic & Medicinal Chemistry Letters|January 9, 2009
Aryl sulphonyl amides as potent agonists of the growth hormone secretagogue (ghrelin) receptorJason Witherington, Lee Abberley, Benjamin R Bellenie, et al.MMWR. Morbidity and Mortality Weekly Report|September 22, 2015
Influenza Vaccination Coverage Among Pregnant Women--United States, 2014-15 Influenza SeasonHelen Ding, Carla L Black, Sarah Ball, et al.Journal of Pain and Symptom Management|May 29, 2004
Polyanalgesic Consensus Conference 2003: an update on the management of pain by intraspinal drug delivery-- report of an expert panelSamuel J Hassenbusch, Russell K Portenoy, Michael Cousins, et al.Bioorganic & Medicinal Chemistry Letters|July 16, 2008
The identification of potent, selective and CNS penetrant furan-based inhibitors of B-Raf kinaseAndrew K Takle, Mark J Bamford, Susannah Davies, et al.Bioorganic & Medicinal Chemistry Letters|October 19, 2007
Potent achiral agonists of the ghrelin (growth hormone secretagogue) receptor. Part I: Lead identificationTom D Heightman, Jackie S Scott, Mark Longley, et al.Annals of Surgery|August 11, 2015
Transfusion of cryopreserved packed red blood cells is safe and effective after trauma: a prospective randomized trialMartin A Schreiber, Belinda H McCully, John B Holcomb, et al.Pageof 27